- Technology and Data
- Front End Sales and Marketing
- Allergy
- HIV
- Women's Health
- Migraine
- Compounding
- Continuous Glucose Monitoring
- Mental Health Awareness
- Veterinary Pharmacy
- CBD
- Infectious Disease
- Eye Health
- Digestive Health
- Biosimilars
- Influenza
- Shingles
- COPD Management
- Pediatrics
- Generics
- Pain Management
- COVID-19
- Immunization
- Oncology
- Anticoagulants
- Autoimmune Diseases
- Dermatology
- Diabetes
- Respiratory
- Heart Health
- Cardiovascular Clinical Consult
Bipartisan pharmacy negotiation bill introduced
Reps. Anthony Weiner (D, N.Y.) and Jerry Moran (R, Kan.) have introduced H.R. 971, the Community Pharmacy Fairness Act of 2007. It would create an exemption to the current antitrust law to allow community pharmacists to cooperatively negotiate contracts with Medicare Part D plans and PBMs. Officials at NCPA, which had lobbied for the bill, hailed it as a significant step for community pharmacists. Still, the prospects for the bill remain unclear. In 2005, Weiner introduced a similar bill that never came to a vote, despite 113 cosponsors. "Under current law, the hands of independent pharmacists are tied because they aren't allowed the same leverage as large chains and others, to negotiate the terms of contracts with health plans," said NCPA executive VP/CEO Bruce Roberts, R.Ph. "Passage of H.R. 971 would give these small business owners the green lightand the cloutto get a better deal for their patients."
To see more Hot off the Press news articles, click here.
To go to the Drug Topics homepage, click here.
